Synopsis
Synopsis
0
JDMF
0
EU WC
0
VMF
0
Canada
0
Australia
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Contugesic
2. Df 118
3. Dhc Continus
4. Dhc Mundipharma
5. Dicodin
6. Dihydrocodeine
7. Dihydrocodeine Acetate, (5alpha,6alpha)-isomer
8. Dihydrocodeine Hydrochloride, (5alpha,6alpha)-isomer
9. Dihydrocodeine Phosphate (1:1), (5alpha,6alpha)-isomer
10. Dihydrocodeine Tartrate (1:1), (5alpha,6alpha)-(r-(r*,r*))-isomer
11. Dihydrocodeine Tartrate (1:1), (5alpha,6beta)-(r-(r*,r*))-isomer
12. Dihydrocodeine, (5alpha,6alpha,14alpha)-isomer
13. Dihydrocodeine, (5alpha,6beta)-isomer
14. Dihydrocodeine, (5alpha,6beta,14alpha)-isomer
15. Dihydrocodeine, Thiocyanate Salt (5alpha,6alpha)-isomer
16. Paracodin
17. Paracodina
18. Paramol 118
19. Rikodeine
20. Tiamon
21. Tosidrin
1. 5965-13-9
2. Df 118
3. Codeine, Dihydro-, Tartrate (1:1)
4. 8lxs95bsa9
5. Tuscodin
6. Dihydrocodeine Bitartrate [usp]
7. Paracodeine Bitartrate
8. Dihydrocodeine Tartrate
9. Dihydrocodeine Acid Tartrate
10. Dihydrocodeine Hydrogen Tartrate
11. Dihydrocodeine Bitartrate (usp)
12. Unii-8lxs95bsa9
13. Nsc-117857
14. (4r,4ar,7s,7ar,12bs)-9-methoxy-3-methyl-2,4,4a,5,6,7,7a,13-octahydro-1h-4,12-methanobenzofuro[3,2-e]isoquinoline-7-ol;(2r,3r)-2,3-dihydroxybutanedioic Acid
15. Einecs 227-747-7
16. Nsc 117857
17. Dtxsid00975047
18. Dihydrocodeine Tartrate [mi]
19. Dihydrocodeine Tartrate [mart.]
20. Dihydrocodeine Bitartrate [vandf]
21. Dihydrocodeine Bitartrate [usp-rs]
22. Dihydrocodeine Bitartrate [who-dd]
23. D03825
24. Dihydrocodeine Bitartrate [orange Book]
25. Dihydrocodeine Bitartrate [usp Monograph]
26. Trezix Component Dihydrocodeine Bitartrate
27. Dhc Plus Component Dihydrocodeine Bitartrate
28. Dihydrocodeine Bitartrate Component Of Dhc Plus
29. Dihydrocodeine Hydrogen Tartrate [ep Monograph]
30. Q27270730
31. Synalgos-dc Component Dihydrocodeine Bitartrate
32. Dihydrocodeine Bitartrate Component Of Synalgos-dc
33. Synalgos-dc-a Component Dihydrocodeine Bitartrate
34. Dihydrocodeine Bitartrate Component Of Synalgos-dc-a
35. 4,5.alpha.-epoxy-3-methoxy-17-methylmorphinan-6a-ol (+)-tartrate (salt)
36. 4,5alpha-epoxy-6alpha-hydroxy-3-methoxy-17-methylmorphinan Hydrogen (r-(r*,r*))-tartrate
37. Morphinan-6-alpha-ol, 4,5-alpha-epoxy-3-methoxy-17-methyl-, Tartrate (1:1)
38. Morphinan-6alpha-ol, 4,5alpha-epoxy-3-methoxy-17-methyl-, Tartrate (1:1) (salt)
39. (4r,4ar,7s,7ar,12bs)-9-methoxy-3-methyl-2,4,4a,5,6,7,7a,13-octahydro-1h-4,12-methanobenzofuro[3,2-e]isoquinolin-7-ol;(2r,3r)-2,3-dihydroxybutanedioic Acid
40. Morphinan-6-ol, 4,5-epoxy-3-methoxy-17-methyl-, (5.alpha.,6.alpha.)-2,3-dihydroxybutanedioate (1:1) (salt)
41. Morphinan-6-ol, 4,5-epoxy-3-methoxy-17-methyl-, (5alpha,6alpha)-, (r-(r*,r*))-2,3-dihydroxybutanedioate (1:1) (salt)
Molecular Weight | 451.5 g/mol |
---|---|
Molecular Formula | C22H29NO9 |
Hydrogen Bond Donor Count | 5 |
Hydrogen Bond Acceptor Count | 10 |
Rotatable Bond Count | 4 |
Exact Mass | 451.18423150 g/mol |
Monoisotopic Mass | 451.18423150 g/mol |
Topological Polar Surface Area | 157 Ų |
Heavy Atom Count | 32 |
Formal Charge | 0 |
Complexity | 605 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 7 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
Analgesics, Opioid
Compounds with activity like OPIATE ALKALOIDS, acting at OPIOID RECEPTORS. Properties include induction of ANALGESIA or NARCOSIS. (See all compounds classified as Analgesics, Opioid.)
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
86
PharmaCompass offers a list of Dihydrocodeine Tartrate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Dihydrocodeine Tartrate manufacturer or Dihydrocodeine Tartrate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Dihydrocodeine Tartrate manufacturer or Dihydrocodeine Tartrate supplier.
PharmaCompass also assists you with knowing the Dihydrocodeine Tartrate API Price utilized in the formulation of products. Dihydrocodeine Tartrate API Price is not always fixed or binding as the Dihydrocodeine Tartrate Price is obtained through a variety of data sources. The Dihydrocodeine Tartrate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A paramol 118 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of paramol 118, including repackagers and relabelers. The FDA regulates paramol 118 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. paramol 118 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of paramol 118 manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A paramol 118 supplier is an individual or a company that provides paramol 118 active pharmaceutical ingredient (API) or paramol 118 finished formulations upon request. The paramol 118 suppliers may include paramol 118 API manufacturers, exporters, distributors and traders.
click here to find a list of paramol 118 suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A paramol 118 DMF (Drug Master File) is a document detailing the whole manufacturing process of paramol 118 active pharmaceutical ingredient (API) in detail. Different forms of paramol 118 DMFs exist exist since differing nations have different regulations, such as paramol 118 USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A paramol 118 DMF submitted to regulatory agencies in the US is known as a USDMF. paramol 118 USDMF includes data on paramol 118's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The paramol 118 USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of paramol 118 suppliers with USDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a paramol 118 Drug Master File in Korea (paramol 118 KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of paramol 118. The MFDS reviews the paramol 118 KDMF as part of the drug registration process and uses the information provided in the paramol 118 KDMF to evaluate the safety and efficacy of the drug.
After submitting a paramol 118 KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their paramol 118 API can apply through the Korea Drug Master File (KDMF).
click here to find a list of paramol 118 suppliers with KDMF on PharmaCompass.
A paramol 118 CEP of the European Pharmacopoeia monograph is often referred to as a paramol 118 Certificate of Suitability (COS). The purpose of a paramol 118 CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of paramol 118 EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of paramol 118 to their clients by showing that a paramol 118 CEP has been issued for it. The manufacturer submits a paramol 118 CEP (COS) as part of the market authorization procedure, and it takes on the role of a paramol 118 CEP holder for the record. Additionally, the data presented in the paramol 118 CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the paramol 118 DMF.
A paramol 118 CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. paramol 118 CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of paramol 118 suppliers with CEP (COS) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing paramol 118 as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for paramol 118 API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture paramol 118 as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain paramol 118 and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a paramol 118 NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of paramol 118 suppliers with NDC on PharmaCompass.
paramol 118 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of paramol 118 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right paramol 118 GMP manufacturer or paramol 118 GMP API supplier for your needs.
A paramol 118 CoA (Certificate of Analysis) is a formal document that attests to paramol 118's compliance with paramol 118 specifications and serves as a tool for batch-level quality control.
paramol 118 CoA mostly includes findings from lab analyses of a specific batch. For each paramol 118 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
paramol 118 may be tested according to a variety of international standards, such as European Pharmacopoeia (paramol 118 EP), paramol 118 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (paramol 118 USP).